APA

Hueb W., Gersh B. J., Rezende P. C., Garzillo C. L., Lima E. G., Vieira R. D., Garcia R. M. R., Favarato D., Segre C. A. W., Pereira A. C., Soares P. R., Ribeiro E., Lemos P., Perin M. A., Strunz C. C., Dallan L. A. O., Jatene F. B., Stolf N. A. G., Hueb A. C., Dias R., Gaiotto F. A., da Costa L. M. A., Oikawa F. T. C., de Melo R. M. V., Serrano C. V., de Ávila L. F. R., Villa A. V., Filho J. R. P., Nomura C., Ramires J. A. F. & Kalil Filho R. (20130129). Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. : BMC cardiovascular disorders.

Chicago

Hueb Whady, Gersh Bernard J, Rezende Paulo Cury, Garzillo Cibele Larrosa, Lima Eduardo Gomes, Vieira Ricardo D'Oliveira, Garcia Rosa Maria Rahmi, Favarato Desiderio, Segre Carlos Alexandre W, Pereira Alexandre Costa, Soares Paulo Rogério, Ribeiro Expedito, Lemos Pedro, Perin Marco A, Strunz Célia Cassaro, Dallan Luis A O, Jatene Fabio B, Stolf Noedir A G, Hueb Alexandre Ciappina, Dias Ricardo, Gaiotto Fabio A, da Costa Leandro Menezes Alves, Oikawa Fernando Teiichi Costa, de Melo Rodrigo Morel Vieira, Serrano Carlos Vicente, de Ávila Luiz Francisco Rodrigues, Villa Alexandre Volney, Filho José Rodrigues Parga, Nomura César, Ramires José A F and Kalil Filho Roberto. 20130129. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. : BMC cardiovascular disorders.

Harvard

Hueb W., Gersh B. J., Rezende P. C., Garzillo C. L., Lima E. G., Vieira R. D., Garcia R. M. R., Favarato D., Segre C. A. W., Pereira A. C., Soares P. R., Ribeiro E., Lemos P., Perin M. A., Strunz C. C., Dallan L. A. O., Jatene F. B., Stolf N. A. G., Hueb A. C., Dias R., Gaiotto F. A., da Costa L. M. A., Oikawa F. T. C., de Melo R. M. V., Serrano C. V., de Ávila L. F. R., Villa A. V., Filho J. R. P., Nomura C., Ramires J. A. F. and Kalil Filho R. (20130129). Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. : BMC cardiovascular disorders.

MLA

Hueb Whady, Gersh Bernard J, Rezende Paulo Cury, Garzillo Cibele Larrosa, Lima Eduardo Gomes, Vieira Ricardo D'Oliveira, Garcia Rosa Maria Rahmi, Favarato Desiderio, Segre Carlos Alexandre W, Pereira Alexandre Costa, Soares Paulo Rogério, Ribeiro Expedito, Lemos Pedro, Perin Marco A, Strunz Célia Cassaro, Dallan Luis A O, Jatene Fabio B, Stolf Noedir A G, Hueb Alexandre Ciappina, Dias Ricardo, Gaiotto Fabio A, da Costa Leandro Menezes Alves, Oikawa Fernando Teiichi Costa, de Melo Rodrigo Morel Vieira, Serrano Carlos Vicente, de Ávila Luiz Francisco Rodrigues, Villa Alexandre Volney, Filho José Rodrigues Parga, Nomura César, Ramires José A F and Kalil Filho Roberto. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial. : BMC cardiovascular disorders. 20130129.